MedPath

Influence of Tricuspid Valve Regurgitation on the short- and long-term survival after Transcatheter Aortic Valve Replacement (TAVR)

Conditions
I35.0
I07.1
Aortic (valve) stenosis
Tricuspid insufficiency
Registration Number
DRKS00022551
Lead Sponsor
niversity Medical Center Schleswig-HolsteinDpt. of Cardiac and Vascular Surgery
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
774
Inclusion Criteria

Aortic Stenosis and Tricuspid-Valve Insufficiency

Exclusion Criteria

no aortic Valve stenosis

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Primary endpoint is defined as 30-day mortality. 2. this defined endpoint and further patients characteristics are routinely requested and sampled at the official institutional data base (registry)
Secondary Outcome Measures
NameTimeMethod
long-term survival
© Copyright 2025. All Rights Reserved by MedPath